Certara（サターラ）について
Certara transforms drug discovery and development for good, helping scientists and clinical teams generate regulatory-grade evidence faster. Its solutions combine biosimulation, clinical intelligence, and regulatory science, and are embedded in the workflows of drug developers worldwide. Certara clients include more than 2,600 biopharmaceutical companies, academic institutions, and global regulatory agencies. 詳細は弊社ホームページをご覧ください。
投資家の皆様：
Erik Abdow
Gilmartin Group
[email protected]
報道機関の皆様：
Sheila Rocchio
[email protected]
